PSUSA/00001686/202411
Submitted by Anonymous (not verified) on 10 September 2025 - 9:52
PSUSA/00001686/202411
PSUSA/00000108/202412
Submitted by Anonymous (not verified) on 10 September 2025 - 9:36
PSUSA/00000108/202412
PSUSA/00010266/202412
Submitted by Anonymous (not verified) on 10 September 2025 - 9:29
PSUSA/00010266/202412
PSUSA/00003067/202412
Submitted by Anonymous (not verified) on 10 September 2025 - 9:20
PSUSA/00003067/202412
PSUSA/00000599/202412
Submitted by Anonymous (not verified) on 10 September 2025 - 9:17
PSUSA/00000599/202412
List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment
Submitted by Anonymous (not verified) on 10 September 2025 - 7:58
List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 10 September 2025, 09:30 (CEST) to 10 September 2025, 13:00 (CEST)
Submitted by Anonymous (not verified) on 10 September 2025 - 7:56
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 10 September 2025, 09:30 (CEST) to 10 September 2025, 13:00 (CEST)
Human medicines European public assessment report (EPAR): Vocabria, cabotegravir, Date of authorisation: 17/12/2020, Revision: 16, Status: Authorised
Submitted by Anonymous (not verified) on 9 September 2025 - 16:20
Human medicines European public assessment report (EPAR): Vocabria, cabotegravir, Date of authorisation: 17/12/2020, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Zinforo, ceftaroline fosamil, Date of authorisation: 22/08/2012, Revision: 29, Status: Authorised
Submitted by Anonymous (not verified) on 9 September 2025 - 16:06
Human medicines European public assessment report (EPAR): Zinforo, ceftaroline fosamil, Date of authorisation: 22/08/2012, Revision: 29, Status: Authorised
Human medicines European public assessment report (EPAR): Revlimid, lenalidomide, Date of authorisation: 14/06/2007, Revision: 54, Status: Authorised
Submitted by Anonymous (not verified) on 9 September 2025 - 15:55
Human medicines European public assessment report (EPAR): Revlimid, lenalidomide, Date of authorisation: 14/06/2007, Revision: 54, Status: Authorised